Crawford Will Lead A Reorganized FDA As McClellan Leaves For CMS
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is implementing a three-deputy commissioner structure on an acting basis to ensure a smooth transition. Selection of a permanent commissioner is unlikely before the November elections.